Study of Maternal and Fetal Cardiovascular Function in Hypertensive States of Pregnancy

Recruiting now

Conditions studied: Preeclampsia

In brief

The pharmacological treatment strategy is then tailored to the underlying hemodynamic phenotype of each patient. That is, rather than applying a one-size-fits-all treatment for all patients, therapy is tailored to the specific characteristics of how the cardiovascular system functions in each patient (e.g., whether the problem is more related to blood volume, vascular resistance, cardiac output, etc.). The goal is to personalize therapy to more effectively treat hypertensive states of pregnancy.

Key facts

Study ID

NCT06858345

Run by

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

People needed

50

Starts

2025-01-01

Expected to finish

2026-01-15

Last updated by the study team

2025-03-05

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Age greater than or equal to 18 years
• Women with singleton and twin pregnancies complicated by hypertensive states of pregnancy.

You may not qualify if…

• Minors under 18 years of age.
• Women with mental disabilities.
• Major congenital fetal anomaly.

Where it is running

• HCUVA — El Palmar, Murcia, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.